About Nobias Therapeutics
an ai-first therapeutics company. nobias is currently running a phase 2 clinical trial for treating symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndr... Read more
an ai-first therapeutics company. nobias is currently running a phase 2 clinical trial for treating symptoms of anxiety, inattention, and autism in children with 22q11 deletion syndr... Read more